The research grouped in this area focuses on the valuation of patient experiences and eliciting preferences for the delivery of healthcare. This work applies stated preference methods in the support of person-centred healthcare.

Current Projects

• Improving the patient-pharmacist interaction: a new approach to help patients make informed decisions

• Lives and livelihoods: understanding public preferences and trade-offs for government responses during a pandemic

• Metastatic prostate cancer men’s Attitude towards Treatment of the local Tumour and metastasis Evaluative Research (MATTER)

• Putting men's preferences at the centre of the doctor-patient relationship: the Prostate cancer treatment preferences (PARTNER) test

• PhD: An economic evaluation of genomic sequencing for the diagnosis of rare conditions in Scotland

• PhD: Public and patient preferences for social prescribing

• PhD: Thriving not surviving: what can time allocation tell us?

• PhD: Using existing data to incorporate broader measures of benefit in economic evaluation

• Should Scotland provide whole genomic sequencing for diagnosis of rare disorders? A health economic analysis

• Supporting shared decision making in early and advanced breast cancer: what matters to patients in an era of personalised care

• Valuing baby boxes: what's important to parents?

Completed Projects

• Applying discrete choice experiments in pharmacy: applied and methodological issues. MRC/ESRC Postdoctoral Fellowship

• A discrete choice experiment to value the personalisation of support for self-management of chronic pain

• Improving the public health sector in South Africa: eliciting public preferences using a discrete choice experiment

• Patients preferences for treatment of lower urinary tract symptoms: a discrete choice experiment

• Person-centred care

• Public attitudes towards drug misuse and drug treatment strategies

• Valuing comprehensive genome sequencing to improve diagnosis of rare disorders: a health economic perspective

• What health care experiences matter to patients and how can we assign value to them for policy making purposes?